Avantor Gestion
Gestion contrôle des critères 3/4
Le PDG Avantor est Emmanuel Ligner, nommé en Aug2025, a un mandat de 1.08 ans. La rémunération annuelle totale est $ 5.90M, composée du salaire de 6.4% et des bonus 93.6%, y compris les actions et options de la société. détient directement 0.018% des actions de la société, d'une valeur de $ 1.91M. La durée moyenne de mandat de l'équipe de direction et du conseil d'administration est respectivement 2.6 ans et 3 ans.
Informations clés
Emmanuel Ligner
Directeur général
US$5.9m
Rémunération totale
| Pourcentage du salaire du PDG | 6.43% |
| Durée du mandat du directeur général | 1.1yrs |
| Propriété du PDG | 0.02% |
| Durée moyenne d'occupation des postes de direction | 2.6yrs |
| Durée moyenne du mandat des membres du conseil d'administration | 3yrs |
Mises à jour récentes de la gestion
Recent updates
Mise à jour du récit • Sep 03
AVTR: Early Turnaround Progress Will Likely Struggle To Sustain Elevated Earnings Multiple
Analysts have lifted the fair value estimate for Avantor to $12 from $7, reflecting a series of higher Street price targets around $12 to $14 that are tied to recent Q2 earnings beats, early progress under the new CEO, and ongoing self help initiatives. Analyst Commentary Recent research updates on Avantor show a cluster of higher fair value and price targets after the Q2 earnings beat and the early phase of the new CEO's plan.Seeking Alpha • Aug 28
Avantor: Smaller Green Shoots Of Organic Growth Returning Are Well Priced In
Summary Avantor has shown stabilization, with organic growth returning and leverage concerns receding as net debt declines. Avantor raised its full-year organic sales and adjusted earnings guidance, signaling a likely return to positive growth in H2. Margin improvement remains a key lever; every 1% margin gain could add $0.10 per share pre-tax, but topline growth is required. Shares have nearly doubled since April, reflecting improved outlook, but current valuations already price in much of the good news. Read the full article on Seeking Alpha
Mise à jour du récit • Aug 14
AVTR: Turnaround Progress And Sector Tailwinds Will Likely Define Next Phase
Analysts have lifted the Avantor fair value estimate from $10.31 to $14.56 after a series of price target increases across the Street. This reflects updated views on discount rate, revenue growth, profit margin, and future P/E assumptions following recent Q2 results and turnaround progress.
Mise à jour du récit • Jul 30
AVTR: Turnaround Execution And Sector Recovery Will Support Future Repricing
Analysts have raised Avantor's fair value estimate from $15.99 to $17.94, reflecting higher price targets across the Street following Q2 results and a management turnaround that is starting to appear in reported margins and growth assumptions. Analyst Commentary Recent Street commentary around Avantor has shifted toward a more constructive tone, with several firms resetting price targets higher following the latest Q2 earnings and early signs of progress under the new leadership team.Mise à jour du récit • Jul 14
AVTR: Sector Tailwinds And Execution Risks Will Likely Shape Next Phase
Avantor's updated analyst price target moves from $9.92 to $10.31, with analysts citing refreshed sector views, recent target hikes into the $10.50 to $11 range, and a higher assumed future P/E multiple as key supports for the revised valuation framework. Analyst Commentary Recent research on Avantor reflects a split view, with some analysts pointing to improving sector conditions and revised price targets, while others focus on ongoing growth and margin challenges.Article d’analyse • Jun 17
Avantor (AVTR) Stock Could Be 34% Below Fair Value After Wolfe Research Downgrade
Wolfe Research’s new Underperform rating on Avantor (AVTR) has put fresh attention on the stock, as the firm pointed to ongoing growth and margin pressures, as well as market share losses in its VWR distribution business. See our latest analysis for Avantor. Avantor’s recent 1 day share price return declined 1.44%, extending a 7 day share price return decline of 3.43%. However, the 30 day share price return rose 25.59%, while the 1 year total shareholder return declined 27.22%. This indicates...Mise à jour du récit • Jun 15
AVTR: Compressed Margins And Shrinking Real Revenue Will Weigh On Future Returns
Analysts have trimmed the fair value estimate for Avantor to $7.00, reflecting a series of lower price targets and continued concerns about shrinking real revenue, margin compression, and execution risk, even though some expectations remain for improved growth and profitability over time. Analyst Commentary Recent Street research on Avantor has leaned cautious, with several bearish analysts cutting price targets and highlighting ongoing operational and profitability challenges.Mise à jour du récit • Jun 01
AVTR: Reset Expectations And Quality Expansion Will Support Turnaround Execution And Repricing
Analysts have trimmed Avantor's fair value estimate by about $0.48 to $15.99, as recent price target cuts and concerns about execution, market share trends, and confidence in the turnaround story temper prior expectations. Analyst Commentary Street research on Avantor has centered on whether the current share price already reflects execution risk and the uncertainties around the turnaround plan.Mise à jour du récit • May 01
AVTR: Reset Expectations And Execution Progress May Support Future Upside
Avantor's updated analyst price target moves lower by several dollars to reflect a reset in fair value to $9.92, as analysts reference reduced price targets across the Street and ongoing questions around market share trends and management execution. Analyst Commentary Recent Street research around Avantor clusters around lower price targets and a downgrade in rating, with most comments focused on valuation reset, market share questions, and confidence in management execution.Mise à jour du récit • Apr 16
AVTR: Expanded Quality Control Capabilities Will Support Execution Turnaround And Future Share Repricing
Analysts have trimmed their average price targets on Avantor, and the updated fair value estimate now stands at about $16.47. This reflects a softer sentiment around the stock as research notes point to share losses, reduced investment, and questions about management's ability to stabilize the business.Mise à jour du récit • Apr 02
AVTR: Reset Expectations And Share Repurchases May Support Future Upside
The analyst price target for Avantor has shifted lower to reflect a series of Street target cuts, including a move to $8.50. This change stems from concerns about share losses, constrained investment, and uncertainty over whether management can stabilize the business.Mise à jour du récit • Mar 19
AVTR: Execution Turnaround In Core Franchise Will Drive Future Share Repricing
Analysts have lowered their price targets on Avantor, with the updated fair value estimate moving from about $17.68 to $16.13 as they factor in concerns about share losses, underinvestment, and uncertainty around management's ability to stabilize the business, along with a higher assumed discount rate and P/E multiple. Analyst Commentary Recent Street research has tilted cautious on Avantor, highlighted by a downgrade to Underweight with a US$8.50 price target and several cuts to prior price targets.Mise à jour du récit • Mar 05
AVTR: Reset Expectations And Buybacks Will Support Future Upside Potential
Analysts have cut their average price target on Avantor by a few dollars to reflect lower fair value estimates, softer assumed revenue growth and profit margins, and a higher future P/E multiple in light of recent broad target reductions from firms across the Street. Several have moved targets in a $2 to $4 range, and one reset its view from $14 to $12.Article d’analyse • Feb 13
The Market Doesn't Like What It Sees From Avantor, Inc.'s (NYSE:AVTR) Revenues Yet As Shares Tumble 27%
Avantor, Inc. ( NYSE:AVTR ) shares have had a horrible month, losing 27% after a relatively good period beforehand...Mise à jour du récit • Feb 04
AVTR: Service Expansion And Execution Will Drive Upside From Reset Expectations
Narrative Update: Avantor Analyst Price Target Shift Analysts recently trimmed their price target on Avantor to $12 from $14. This reflects updated views on the life science tools sector and a Q4 outlook where many companies have already set softer expectations for 2026.Mise à jour du récit • Jan 21
AVTR: Share Repurchases And Execution Risks Will Shape Turnaround Visibility
Analysts have trimmed their price target on Avantor by about $0.60, reflecting more cautious assumptions on revenue growth and future P/E. This is partly offset by slightly higher profit margin expectations and a marginally lower discount rate.Mise à jour du récit • Jan 07
AVTR: Execution Turnaround And Review Process Will Unlock Share Repricing Potential
Avantor's analyst price targets and fair value estimates have inched higher to around $17.68 per share. At the same time, lower assumed revenue growth, a higher discount rate, a reduced future P/E, and sharply higher profit margin expectations reflect analysts' mixed views following recent downgrades and concerns about execution and visibility.Mise à jour du récit • Dec 14
AVTR: Share Repurchases Will Drive Upside As Turnaround Visibility Improves
Analysts have modestly lowered their price targets on Avantor by a few dollars per share, generally to the low to mid teens in dollar terms. They cite reduced guidance, weaker quarters and limited visibility around the company’s turnaround and strategic review.Mise à jour du récit • Nov 28
AVTR: Share Repurchase Initiative And Execution Will Shape Recovery Prospects Ahead
Analysts have lowered their price target for Avantor from $14 to $12 per share, citing a weak quarter, reduced guidance, and ongoing execution risks as primary concerns behind the updated outlook. Analyst Commentary Bullish Takeaways Bullish analysts have raised price targets ahead of quarterly results, reflecting improved confidence in Avantor’s long-term positioning despite current volatility.Mise à jour du récit • Nov 14
AVTR: Share Repurchase And Execution Will Define Turnaround Prospects In 2025
Avantor’s analyst price target has decreased from $13.80 to $13.64. Analysts cite reduced company guidance, execution risks, and ongoing uncertainty surrounding its earnings outlook as key factors driving the revision.Article d’analyse • Nov 01
Avantor, Inc. Reported A Surprise Loss, And Analysts Have Updated Their Forecasts
There's been a major selloff in Avantor, Inc. ( NYSE:AVTR ) shares in the week since it released its third-quarter...Mise à jour du récit • Oct 31
AVTR: Activist Pressure And Business Overhaul Will Drive Share Recovery
Avantor’s analyst price target has been reduced from $14.40 to $13.80 per share, as analysts cite ongoing operational headwinds and limited near-term earnings visibility following recent downgrades and mixed guidance. Analyst Commentary Recent analyst notes on Avantor capture a divided outlook, reflecting both positive updates from some firms and notable caution from others as the company contends with ongoing operational challenges.Article d’analyse • Oct 28
There's No Escaping Avantor, Inc.'s (NYSE:AVTR) Muted Earnings Despite A 28% Share Price Rise
Avantor, Inc. ( NYSE:AVTR ) shares have had a really impressive month, gaining 28% after a shaky period beforehand...Mise à jour du récit • Oct 16
Pharma Contracts And R&D Will Drive Growth Amid Price Pressures
Analysts have modestly increased their price target for Avantor, raising it by $0.28 to $14.40. They cite revised expectations for end market recovery and alignment with company outlooks.Seeking Alpha • Apr 26
Avantor: A Healthier Diagnosis As Expectations Cool
Summary Avantor's shares have nearly halved since October, driven by lackluster organic growth, elevated debt, and a mixed financial track record. The company operates in two segments, generating nearly $7 billion in sales, with significant exposure to laboratory solutions and bioscience production. Despite a reduction in net debt and lower earnings multiples, the business faces ongoing challenges, including flat organic growth and a high leverage ratio. The risk-reward profile has improved due to lower expectations, but the outlook remains cautious amidst continued sales declines and pending leadership changes. Read the full article on Seeking AlphaSeeking Alpha • Mar 07
Avantor: Mundane Business, Solid Cash Flow, Potential New Risks
Summary Avantor, Inc. has seen a significant decline in its stock price recently. The company did divest itself of one business this summer, paying down some debt with the proceeds. In addition, the company delivered an impressive amount of free cash flow in FY2024. Buy, Sell or Hold? An analysis around AVTR stock follows in the paragraphs below. Read the full article on Seeking AlphaSeeking Alpha • Dec 18
Avantor: Durable FCF Generator Trading For Cheap
Summary Avantor's robust business model yields stable cash flows and generates sticky customers. Avantor’s leadership in the biopharma industry and shifting revenue mix can produce considerable margin expansion. Significant FCF generation can improve the company’s capital structure and return value to shareholders. Potential industry inflection point creates optimal entry point with multiple expansion. Read the full article on Seeking AlphaAnalyse de la rémunération des PDG
| Date | Rémunération totale | Salaire | Bénéfices de l'entreprise |
|---|---|---|---|
| Jun 30 2026 | n/a | n/a | -US$578m |
| Mar 31 2026 | n/a | n/a | -US$551m |
| Dec 31 2025 | US$6m | US$379k | -US$530m |
Rémunération vs marché: La rémunération totale de Emmanuel ($USD 5.90M ) est inférieure à la moyenne des entreprises de taille similaire sur le marché US ($USD 14.74M ).
Rémunération et revenus: Données insuffisantes pour comparer la rémunération de Emmanuel avec les performances de l'entreprise.
PDG
Emmanuel Ligner (55 yo)
1.1yrs
Titularisation
US$5,895,624
Compensation
Mr. Emmanuel Ligner is President and Chief Executive Officer of Avantor, Inc. from August 18, 2025 and serves as its Director. He was Chief Executive Officer of Cerba HealthCare S.A.S. from March 01, 2024...
Équipe de direction
| Nom | Position | Titularisation | Compensation | Propriété |
|---|---|---|---|---|
| President | 1.1yrs | US$5.90m | 0.018% $ 1.9m | |
| Executive VP | 3.2yrs | US$3.75m | 0.0037% $ 387.3k | |
| President of Laboratory Solutions | 2.3yrs | US$5.99m | 0.0033% $ 348.5k | |
| Executive Vice President of Bioscience Production | 2.9yrs | US$5.23m | 0.0037% $ 385.2k | |
| Senior VP | 7.3yrs | pas de données | 0.019% $ 2.0m | |
| Executive VP & COO | less than a year | pas de données | pas de données | |
| Executive VP & Chief Information Officer | 8.4yrs | US$3.19m | pas de données | |
| Vice President of Investor Relations | less than a year | pas de données | pas de données | |
| Executive VP & Chief Human Resources Officer | 3.1yrs | pas de données | 0.037% $ 3.9m | |
| Executive Vice President of AMEA | 8.4yrs | pas de données | 0.0089% $ 929.0k | |
| EVP of Bioscience & Medtech Products and Chief Transformation Officer | less than a year | pas de données | pas de données | |
| Executive Vice President of Quality & Regulatory | less than a year | pas de données | pas de données |
2.6yrs
Durée moyenne de l'emploi
56yo
Âge moyen
Gestion expérimentée: L'équipe de direction de AVTR est considérée comme expérimentée (ancienneté moyenne 2.6 ans).
Membres du conseil d'administration
| Nom | Position | Titularisation | Compensation | Propriété |
|---|---|---|---|---|
| President | no data | US$5.90m | 0.018% $ 1.9m | |
| Independent Chairman of the Board | 6.3yrs | US$329.99k | 0.065% $ 6.8m | |
| Independent Director | less than a year | US$151.26k | 0.0089% $ 931.1k | |
| Independent Director | 1.8yrs | US$332.58k | 0.00071% $ 74.5k | |
| Independent Director | 4.8yrs | US$329.99k | 0.0052% $ 543.7k | |
| Chair of Scientific Advisory Board | 3yrs | US$3.09m | pas de données | |
| Independent Director | 6.4yrs | US$324.99k | 0.0064% $ 673.9k | |
| Member of Scientific Advisory Board | 3yrs | pas de données | pas de données | |
| Independent Director | 4.9yrs | US$317.49k | 0.0040% $ 420.9k | |
| Member of Scientific Advisory Board | 3yrs | pas de données | pas de données | |
| Member of Scientific Advisory Board | 3yrs | pas de données | pas de données | |
| Member of Scientific Advisory Board | 2.7yrs | pas de données | pas de données |
3.0yrs
Durée moyenne de l'emploi
61yo
Âge moyen
Conseil d'administration expérimenté: Les membres du conseil d'administration de AVTR sont considérés comme expérimentés (ancienneté moyenne 3 ans).
Analyse de l'entreprise et données financières
| Données | Dernière mise à jour (heure UTC) |
|---|---|
| Analyse de l'entreprise | 2026/09/21 08:09 |
| Cours de l'action en fin de journée | 2026/09/18 00:00 |
| Les revenus | 2026/06/30 |
| Revenus annuels | 2025/12/31 |
Sources de données
Les données utilisées dans notre analyse de l'entreprise proviennent de S&P Global Market Intelligence LLC. Les données suivantes sont utilisées dans notre modèle d'analyse pour générer ce rapport. Les données sont normalisées, ce qui peut entraîner un délai avant que la source ne soit disponible.
| Paquet | Données | Cadre temporel | Exemple de source américaine * |
|---|---|---|---|
| Finances de l'entreprise | 10 ans |
| |
| Estimations consensuelles des analystes | +3 ans |
|
|
| Prix du marché | 30 ans |
| |
| Propriété | 10 ans |
| |
| Gestion | 10 ans |
| |
| Principaux développements | 10 ans |
|
* Exemple pour les titres américains ; pour les titres non américains, des formulaires réglementaires et des sources équivalentes sont utilisés.
Sauf indication contraire, toutes les données financières sont basées sur une période annuelle mais mises à jour trimestriellement. C'est ce qu'on appelle les données des douze derniers mois (TTM) ou des douze derniers mois (LTM). En savoir plus.
Modèle d'analyse et flocon de neige
Les détails du modèle d’analyse utilisé pour générer ce rapport sont disponibles sur notre page Github ; nous proposons également des guides sur la façon d’utiliser nos rapports et des tutoriels sur YouTube.
Découvrez l' qui a conçu et construit le modèle d'analyse Simply Wall St.
Indicateurs de l'industrie et du secteur
Nos indicateurs de secteur et de section sont calculés toutes les 6 heures par Simply Wall St. Les détails de notre processus sont disponibles sur Github.
Sources des analystes
Avantor, Inc. est couverte par 30 analystes. 16 de ces analystes ont soumis les estimations de revenus ou de bénéfices utilisées comme données d'entrée dans notre rapport. Les soumissions des analystes sont mises à jour tout au long de la journée.
| Analyste | Institution |
|---|---|
| Robert Bamberger | Baird |
| Catherine Ramsey Schulte | Baird |
| Luke Sergott | Barclays |